MediPharm Labs Corp.LABS.TO

Health Care · Pharmaceuticals, Biotechnology & Life Sciences · TSX · Canada · medipharmlabs.com

MediPharm Labs Corp. is a GMP-certified cannabis pharmaceutical manufacturer based in Barrie, Ontario, Canada. The company produces pharmaceutical-quality cannabis extracts, concentrates, and active pharmaceutical ingredients for medical markets in Canada, Australia, and Germany. MediPharm holds a Pharmaceutical Drug Establishment License from Health Canada and a U.S. FDA site registration for cannabis pharmaceutical manufacturing.

Key ratios

FCF / Sales

-12.4%TTM

2025 -12.4%2024 -12.0%2023 -38.7%

Net margin

-18.3%TTM

2025 -18.3%2024 -25.5%2023 -39.6%

ROA

-10.6%TTM

2025 -10.6%2024 -9.3%2023 -12.9%

ROE

-20.9%TTM

2025 -20.9%2024 -22.2%2023 -24.0%

Recent news

MediPharm Labs Reports Positive Q2 2026 Net Income and Second Consecutive Quarter of Positive Adjusted EBITDA 2026-08-13 · GlobeNewswire MediPharm Labs Sets Date to Report Second Quarter 2026 Financial Results 2026-08-10 · GlobeNewswire MediPharm Labs Announces Voting Results from the 2026 Annual and Special Meeting of Shareholders 2026-06-17 · GlobeNewswire MediPharm Labs Reports First Quarter 2026 Results Achieving Positive Adjusted EBITDA 2026-05-13 · GlobeNewswire

Track LABS.TO in your journal

Save it to a watchlist, run a reverse DCF, and keep your notes on the company in one place. Free to start.

Create a free account

Figures are sourced from third parties and shown for research only. They may be delayed or incomplete, and nothing on this page is investment advice or a recommendation to buy or sell. Read the full disclaimer